Principal Financial Group Inc Catalent, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 208,206 shares of CTLT stock, worth $12.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,206
Previous 207,977 0.11%
Holding current value
$12.6 Million
Previous $11.7 Million 7.84%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$56.16 - $60.96 $12,860 - $13,959
229 Added 0.11%
208,206 $12.6 Million
Q2 2024

Jul 29, 2024
BUY
$53.58 - $57.02 $68,743 - $73,156
1,283 Added 0.62%
207,977 $11.7 Million
Q1 2024

Apr 29, 2024
BUY
$42.56 - $59.82 $148,917 - $209,310
3,499 Added 1.72%
206,694 $11.7 Million
Q4 2023

Feb 07, 2024
SELL
$32.18 - $46.57 $115,333 - $166,906
-3,584 Reduced 1.73%
203,195 $9.13 Million
Q3 2023

Nov 02, 2023
SELL
$44.2 - $50.2 $121,815 - $138,351
-2,756 Reduced 1.32%
206,779 $9.41 Million
Q2 2023

Aug 07, 2023
SELL
$31.86 - $67.26 $362,726 - $765,755
-11,385 Reduced 5.15%
209,535 $9.09 Million
Q1 2023

May 09, 2023
BUY
$45.44 - $74.26 $148,906 - $243,350
3,277 Added 1.51%
220,920 $14.5 Million
Q4 2022

Feb 09, 2023
SELL
$41.39 - $81.0 $196,271 - $384,102
-4,742 Reduced 2.13%
217,643 $9.79 Million
Q3 2022

Nov 09, 2022
SELL
$72.36 - $113.1 $286,690 - $448,102
-3,962 Reduced 1.75%
222,385 $16.1 Million
Q2 2022

Aug 10, 2022
BUY
$87.2 - $114.05 $540,291 - $706,653
6,196 Added 2.81%
226,347 $24.3 Million
Q1 2022

May 09, 2022
BUY
$94.19 - $124.49 $914,396 - $1.21 Million
9,708 Added 4.61%
220,151 $24.4 Million
Q4 2021

Feb 09, 2022
SELL
$119.57 - $139.07 $490,476 - $570,465
-4,102 Reduced 1.91%
210,443 $26.9 Million
Q3 2021

Nov 09, 2021
BUY
$109.17 - $142.35 $292,248 - $381,070
2,677 Added 1.26%
214,545 $28.6 Million
Q2 2021

Aug 10, 2021
BUY
$100.34 - $115.69 $602,040 - $694,140
6,000 Added 2.91%
211,868 $22.9 Million
Q1 2021

May 10, 2021
SELL
$101.51 - $125.27 $941,302 - $1.16 Million
-9,273 Reduced 4.31%
205,868 $21.7 Million
Q4 2020

Feb 08, 2021
SELL
$85.88 - $105.36 $1.4 Million - $1.72 Million
-16,330 Reduced 7.05%
215,141 $22.4 Million
Q3 2020

Nov 06, 2020
SELL
$72.74 - $92.5 $19.5 Million - $24.8 Million
-267,908 Reduced 53.65%
231,471 $19.8 Million
Q2 2020

Aug 05, 2020
BUY
$48.02 - $79.04 $1.36 Million - $2.23 Million
28,272 Added 6.0%
499,379 $36.6 Million
Q1 2020

May 12, 2020
SELL
$36.95 - $62.95 $5.95 Million - $10.1 Million
-161,067 Reduced 25.48%
471,107 $24.5 Million
Q4 2019

Feb 05, 2020
BUY
$47.06 - $56.64 $56,989 - $68,591
1,211 Added 0.19%
632,174 $35.6 Million
Q3 2019

Nov 13, 2019
SELL
$47.45 - $58.05 $484,037 - $592,168
-10,201 Reduced 1.59%
630,963 $30.1 Million
Q2 2019

Aug 12, 2019
SELL
$39.26 - $54.21 $156,333 - $215,864
-3,982 Reduced 0.62%
641,164 $34.8 Million
Q1 2019

May 10, 2019
BUY
$29.84 - $43.92 $258,086 - $379,864
8,649 Added 1.36%
645,146 $26.2 Million
Q4 2018

Feb 14, 2019
SELL
$29.95 - $46.34 $349,097 - $540,139
-11,656 Reduced 1.8%
636,497 $19.8 Million
Q3 2018

Nov 14, 2018
BUY
$40.12 - $45.55 $2.15 Million - $2.44 Million
53,587 Added 9.01%
648,153 $29.5 Million
Q2 2018

Aug 13, 2018
BUY
$38.72 - $42.52 $500,572 - $549,698
12,928 Added 2.22%
594,566 $0
Q1 2018

May 14, 2018
BUY
$39.4 - $47.39 $403,810 - $485,700
10,249 Added 1.79%
581,638 $23.9 Million
Q4 2017

Feb 13, 2018
BUY
$37.27 - $43.02 $470,906 - $543,557
12,635 Added 2.26%
571,389 $23.5 Million
Q3 2017

Nov 02, 2017
BUY
$33.75 - $41.67 $18.9 Million - $23.3 Million
558,754
558,754 $22.3 Million

Others Institutions Holding CTLT

# of Institutions
514
Shares Held
149M
Call Options Held
575K
Put Options Held
2.03M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email